Sign in

CIK 0001472012 · Non-accelerated filer

Immunome Inc.

Sign in to watch
Ticker
IMNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770694340
Phone
610-321-3700
Business address
18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$334,224
in 1 filing, $334K under 10b5-1 plans

Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Higgins Jack −$334K Chief Scientific Officer sold 17% of stake

Reading 56 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-08-15 Higgins Jack Chief Scientific Officer Option exercise · Stock option (right to buy) −19,524 179,040
2024-08-09 SIEGALL CLAY B President and CEO Grant or award · Stock option (right to buy) +800,000 800,000
2024-08-09 Stoneman Sandra G. CHIEF LEGAL OFFICER & GC Grant or award · Stock option (right to buy) +210,000 210,000
2024-08-09 Horn Kinney CHIEF BUSINESS OFFICER Grant or award · Stock option (right to buy) +130,000 130,000
2024-08-09 Turner Bruce Chief Strategy Officer Grant or award · Stock option (right to buy) +110,000 110,000
2024-08-09 Rosett Max EVP, Operations & CFO Grant or award · Stock option (right to buy) +190,000 190,000
2024-08-09 Lechleider Robert Chief Medical Officer Grant or award · Stock option (right to buy) +200,000 200,000
2024-08-09 Higgins Jack Chief Scientific Officer Grant or award · Stock option (right to buy) +190,000 190,000
2024-06-17 Tsai Philip Chief Technology Officer Grant or award · Stock option (right to buy) +250,000 250,000
2024-06-13 Boylan James P Director Grant or award · Stock option (right to buy) +11,333 11,333
2024-06-13 SCHAFER CAROL Director Grant or award · Stock option (right to buy) +11,333 11,333
2024-06-13 SWAIN SANDRA M Director Grant or award · Stock option (right to buy) +11,333 11,333
2024-06-13 WAGENHEIM PHILIP Director Grant or award · Stock option (right to buy) +11,333 11,333
2024-06-13 BIENAIME JEAN JACQUES Director Grant or award · Stock option (right to buy) +11,333 11,333
2024-06-13 Barchas Isaac Director Grant or award · Stock option (right to buy) +11,333 11,333
2024-05-21 BIENAIME JEAN JACQUES Director Purchase +2,000 $13.57 $27K 9,615
2024-05-21 SIEGALL CLAY B President and CEO Purchase +20,434 $13.78 $282K 419,636
2024-05-20 SIEGALL CLAY B President and CEO Purchase +79,566 $13.91 $1.1M 399,202
2024-05-16 Rosett Max EVP, Operations & CFO Grant or award · Stock option (right to buy) +30,000 30,000
2024-04-25 SWAIN SANDRA M Director Grant or award · Stock option (right to buy) +25,737 25,737

Page 7 of 8 · 159 trades